Alogliptin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 13 USDMF, 1 JDMF, 9 EU WC, 11 KDMF, 6 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

28 API Suppliers

28 API Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 19 FDA Orange Book, 22 Europe, 6 Canada, 6 Australia, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12.5MG BASE;1GM, TABLET;ORAL - EQ 12.5MG BASE;500MG, TABLET;ORAL - EQ 12.5MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 6.25MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 5 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 19 Kerry, 12 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 13 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 32 Direct Compression, 18 Granulation, 16 Disintegrants & Superdisintegrants, 15 Co-Processed Excipients, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 11 Taste Masking, 11 Chewable & Orodispersible Aids, 10 Coating Systems & Additives, 8 Controlled & Modified Release, 7 Parenteral, 7 Solubilizers, 5 Film Formers & Plasticizers, 3 Coloring Agents, 2 Rheology Modifiers, 1 API Stability Enhancers, 1 Emulsifying Agents